Galedra
Sign in Sign up

Evidence item

The 45-eye randomized trial found greater 24-month IOP and medication reductions and higher GATT success rates, with no significant difference in reoperations. DIRECT_TEXT

Authenticity UNVERIFIED · extraction UNVERIFIED · independence group none (unreviewed) · created seq 24309

Source: Bent ab interno needle goniotomy versus gonioscopy-assisted transluminal trabeculotomy in primary open angle glaucoma: a randomised clinical trial, 24-month outcomes · locator {} · excerpt hash sha256:68ec3923e9a66d15f289372132ec51223c522fb62ff1a20bef49ffbc73278dff

Exact excerpt
A total of 45 eyes (22 BANG and 23 GATT) were included. At endpoint, in the BANG and GATT groups, mean IOPs were reduced by 16.0% and 22.44% (time-group analysis: p = 0.048), whereas medication was reduced by 6.22% and 69.78% (time-group analysis: p < 0.01), respectively. GATT eyes achieved higher rates of complete (55.0% vs. 4.5%) and qualified success (64.7% vs. 11.4%). Additional surgery was needed in 3 (13.63%) BANG eyes and 4 (18.18%) GATT eyes (p = 1.0).

Linked claims

ClaimDirectionRelevanceStepsCounted
0d6940e3SUPPORTDIRECT0yes

Audits

None.